Yan, Yongxiang
Wuhan YZY Biopharma (China)
2 papers on CoChat
Most cited papers
- Verified
The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1
Yi, M., Zhang, J., Li, A., Niu, M., Yan, Y., Jiao, Y., Luo, S., Zhou, P., & Wu, K. (2021) · Journal of Hematology & Oncology
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 233
- Verified
Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers
Yi, M., Niu, M., Zhang, J., Li, S., Zhu, S., Yan, Y., Li, N., Zhou, P., Chu, Q., & Wu, K. (2021) · Journal of Hematology & Oncology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 163
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free